These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7759207)

  • 1. Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.
    Sasagawa I; Nakada T; Kubota Y; Sawamura T; Suzuki H; Hashimoto T
    Int Urol Nephrol; 1994; 26(6):701-5. PubMed ID: 7759207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of subcutaneous administration of recombinant human erythropoietin on plasma protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Yin JA; Li PK; Yuen PM; Lui SF
    Int J Artif Organs; 1992 May; 15(5):264-8. PubMed ID: 1601509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anemia in peritoneal dialysis patients].
    Lausević M; Nesić V; Jovanović N; Stojimirović B
    Srp Arh Celok Lek; 2006; 134(3-4):133-7. PubMed ID: 16915754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell cation transports in uraemic anaemia: evidence for an increased K/Cl co-transport activity. Effects of dialysis and erythropoietin treatment.
    De Franceschi L; Olivieri O; Girelli D; Lupo A; Bernich P; Corrocher R
    Eur J Clin Invest; 1995 Oct; 25(10):762-8. PubMed ID: 8557063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R; Bloom E; Johnson R
    Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis.
    Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P
    Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y; Ito K
    Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Di Paolo B; Marini A; Fiederling B; Di Liberato L; Santarelli P; Bucciarelli S; Stuard S; Paolantonio L; Albertazzi A
    Perit Dial Int; 1993; 13 Suppl 2():S538-40. PubMed ID: 8399659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S; Kaku Y; Ueda K; Onoyama K
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Law CB; Ting SM; Li P; Lai KN
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy.
    Caravaca F; López-Minguez JR; Arrobas M; Cubero J; Pizarro JL; Cid MC; Sanchez-Casado E; Miranda MP
    Nephrol Dial Transplant; 1995; 10(9):1720-4. PubMed ID: 8559495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
    Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.
    Díez JJ; Iglesias PL; Sastre J; Gómez-Pan A; Selgas R; Martínez-Ara J; Miguel JL; Méndez J
    Kidney Int; 1994 Nov; 46(5):1387-91. PubMed ID: 7853798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and sexual dysfunction.
    Lawrence IG; Price DE; Howlett TA; Harris KP; Feehally J; Walls J
    Nephrol Dial Transplant; 1997 Apr; 12(4):741-7. PubMed ID: 9141005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC; Lee EJ
    Adv Perit Dial; 1991; 7():285-7. PubMed ID: 1680447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
    Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
    Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.